Bayer AS
Score · fiscal year 2025
73of 100
How to read this: the company is ahead of 91 % of companies in the Morning class Large in the same sector in 2025. What does this mean?
Rank in the Morning class Large: 50 of 541 · What are Morning company classes?
Place in the whole sector: 2,388 of 22,952 · Handel
Profile
Lion · Leader
High profitability, high solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 98 and solidity 58 out of 100 among companies in the Morning class Large in the same sector in 2025. Methodology
Against the sector
Bayer AS is 23 points above the median for companies in the Morning class Large in the same sector in 2025.
Median score 50 among 541 companies.
Against companies in the Morning class Large in the same sector in 2025: operating margin 29.6% (median 2.5%) and equity ratio 35.6% (median 30.9%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 1,951 MNOK | 1,119 MNOK |
| Operating margin | 29.6% | 2.5% |
| Profit margin | 30.8% | 2.5% |
| Return on assets | 39.3% | 10.2% |
| Equity ratio | 35.6% | 30.9% |
| Debt-to-equity | 1.81 | 2.23 |
| Current ratio | 1.40 | 1.30 |
| Revenue growth | 40.1% | 6.9% |
| Revenue per employee | 15.24 MNOK | 12.49 MNOK |
The median and “ahead of” refer to companies in the Morning class Large in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 73, Bayer AS does better than 91% of companies in the Morning class Large in the same sector (541 companies) in 2025.
Score 2023–2025
- Bayer AS
- Median: companies in the Morning class Large in the same sector
Bayer AS has a score of 73 for 2025, rank 2,388 of 22,952 in the sector.
Strongest: Profitability: percentile 98 against peers, operating margin 29.6% against a median of 2.5%. Growth: percentile 92 against peers, revenue growth 40.1% against a median of 6.9%.
No area is clearly below its peers.
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
Bayer AS had an operating margin of 29.6% and an equity ratio of 35.6% in 2025, and ranks 2,388 of 22,952 in Handel.
From 2024 to 2025: revenue grew by 40% and the operating margin rose from 21.9% to 29.6%.
This text is generated automatically from the 2025 accounts.
Three simple methods
The methods give between 46 MEUR and 400 MEUR.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 400 MEUR |
| EV/EBIT | 8.0 | 394 MEUR |
| P/B | 1.0 | 46 MEUR |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
No rules were triggered for this year.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were −0.7% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
- watch Reports in a currency other than NOK
Scenario analysis: the sector's weakest year
We have no accounts for 2022, the sector's weakest year, for this company.
The sector's weakest year was 2022, with a median operating margin of 1.5%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 98 | weight 30% |
|---|---|---|
| Solidity | 58 | weight 25% |
| Liquidity | 57 | weight 15% |
| Growth | 92 | weight 15% |
| Consistency | 43 | weight 15% |
Durability: 76 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is Bayer AS?
The operating margin was 29.6% in 2025, against a median of 2.5% among companies in the Morning class Large in the same sector. Return on assets was 39.3%.
How solid is Bayer AS?
The equity ratio was 35.6% in 2025 (median 30.9%). Debt-to-equity was 1.81 (median 2.23).
What is the liquidity of Bayer AS like?
The current ratio was 1.40 in 2025 (median 1.30).
How does Bayer AS compare in Handel?
Bayer AS ranks 2,388 of 22,952 in Handel for 2025. Among companies in the Morning class Large it is number 50 of 541. Revenue changed by 40.1% from the year before.
Group accounts
The company is registered as part of a group, but we have no group accounts for it. Group accounts are filed by the parent company, and open data does not say which company that is.
Read the figures with care: a company in a group can look strong because of group contributions, or weak because dividends go up to the parent. The figures are indications, not the full picture.
We do not show the group structure, because open data does not say who owns whom.
From the Central Coordinating Register
- Org. no.
- 911268647
- Legal form
- AS · part of a group
- Sector
- Handel (46.460)
- Morning company class
- Large
- Employees
- 128 registered 10 September 2026
- Founded
- 30 September 1964 62 years in operation
- Share capital
- 5.13 MNOK
- Business address
- Drammensveien 288, 0283 OSLO
- Municipality
- Oslo rank 63–220 of 357 in Norway
- Latest accounts filed
- 2025
- Website
- www.bayer.no
- LEI
- 5299007BEUORYZGQZH08 renews 11 April 2027
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chief executive
- Erik Helstad
- Chair of the board
- Erik Helstad
- Board member
- Ann-Christin Siltvedt
- Board member
- Gro Salberg
- Board member
- Therese Andersen
- Board member
- Thomas Birger Edén-Jensen
- Board member
- Anita Sollie
- Deputy member
- Gørild Thuen Jensen
- Deputy member
- Axel Berg-Larsen
- Deputy member
- Milosz Grzegorz Rolinski
- Auditor
- Deloitte AS
- Accountant
- Azets Insight AS
Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.
- Parent company
- Bayer Aktiengesellschaft (Germany)
Foreign-owned according to GLEIF.
Source: GLEIF (Global Legal Entity Identifier Foundation), fetched 29 October 2026. The parent is the one the company itself reported to GLEIF.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 26 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 80 | 74 | 73 | |
| Rank | 1,894 | 2,062 | 2,388 | |
| Operating margin | 40.7% | 21.9% | 29.6% | |
| Return on assets | 50.4% | 28.6% | 39.3% | |
| Equity ratio | 38.4% | 51.8% | 35.6% | |
| Current ratio | 1.45 | 1.79 | 1.40 | |
| Revenue growth | – | −28.0% | 40.1% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (EUR). Revenue in NOK is converted from EUR at the mean rate for the accounting period 1 January 2025–31 December 2025: 11.7177 (norges_bank). Balance-sheet amounts use the rate on the balance-sheet date. Ratios and growth are computed in EUR. Exchange rates at Norges Bank
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 165.1 MEUR | 118.8 MEUR | 166.5 MEUR |
| Operating profit | 67.2 MEUR | 26.0 MEUR | 49.2 MEUR |
| Profit before tax | 67.5 MEUR | 27.9 MEUR | 51.2 MEUR |
| Net profit | 52.5 MEUR | 23.9 MEUR | 40.0 MEUR |
| Financial expenses | 0.2 MEUR | −0.5 MEUR | −0.6 MEUR |
| Total assets | 134.3 MEUR | 96.1 MEUR | 129.0 MEUR |
| Current assets | 119.8 MEUR | 82.9 MEUR | 116.2 MEUR |
| Equity | 51.6 MEUR | 49.8 MEUR | 45.9 MEUR |
| Retained earnings | 51.1 MEUR | 49.3 MEUR | 45.4 MEUR |
| Total liabilities | 82.6 MEUR | 46.3 MEUR | 83.1 MEUR |
| Current liabilities | 82.5 MEUR | 46.2 MEUR | 83.0 MEUR |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 26 October 2026, accounts id 6855466.
Further
Similar companies
- Mrc Global Norway AS index 73, rank 2,205 · compare
- Rituals Cosmetics Norway AS index 73, rank 2,292 · compare
- Astrazeneca AS index 72, rank 2,451 · compare
- Cloetta Norge AS index 72, rank 2,523 · compare
- Takeda AS index 72, rank 2,559 · compare